In 2024, South Korean cosmetics company Neopharm spent approximately *** billion South Korean won on research and development (R&D), marking an increase from the previous year. The company saw a significant rise in R&D expenses between 2017 and 2018, with spending reaching its highest level in 2024.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
DART. (March 17, 2025). Research and development (R&D) expenses of NeoPharm from 2017 to 2024 (in million South Korean won) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1362991/neopharm-research-and-development-expenses/
DART. "Research and development (R&D) expenses of NeoPharm from 2017 to 2024 (in million South Korean won)." Chart. March 17, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1362991/neopharm-research-and-development-expenses/
DART. (2025). Research and development (R&D) expenses of NeoPharm from 2017 to 2024 (in million South Korean won). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1362991/neopharm-research-and-development-expenses/
DART. "Research and Development (R&d) Expenses of Neopharm from 2017 to 2024 (in Million South Korean Won)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Mar 2025, /statistics/1362991/neopharm-research-and-development-expenses/
DART, Research and development (R&D) expenses of NeoPharm from 2017 to 2024 (in million South Korean won) ÌÇÐÄÆƽâ°æ, /statistics/1362991/neopharm-research-and-development-expenses/ (last visited July 22, 2026)
Research and development (R&D) expenses of NeoPharm from 2017 to 2024 (in million South Korean won) [Graph], DART, March 17, 2025. [Online]. Available: /statistics/1362991/neopharm-research-and-development-expenses/
